{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:21:13Z","timestamp":1776907273501,"version":"3.51.2"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>Obesity is an emerging condition, with a prevalence of ~20%. Although the simple measurement of BMI is likely a simplistic approach to obesity, BMI is easily calculated, and there are currently no data showing that more sophisticated methods are more useful to guide the endocrine work-up in obesity. An increased BMI leads to a number of hormonal changes. Additionally, concomitant hormonal diseases can be present in obesity and have to be properly diagnosed \u2013 which in turn might be more difficult due to alterations caused by body fatness itself. The present European Society of Endocrinology Clinical Guideline on the Endocrine Work-up in Obesity acknowledges the increased prevalence of many endocrine conditions in obesity. It is recommended to test all patients with obesity for thyroid function, given the high prevalence of hypothyroidism in obesity. For hypercortisolism, male hypogonadism and female gonadal dysfunction, hormonal testing is only recommended if case of clinical suspicion of an underlying endocrine disorder. The guideline underlines that weight loss in obesity should be emphasized as key to restoration of hormonal imbalances and that treatment and that the effect of treating endocrine disorders on weight loss is only modest.<\/jats:p>","DOI":"10.1530\/eje-19-0893","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T16:34:55Z","timestamp":1580142895000},"page":"G1-G32","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":147,"title":["European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity"],"prefix":"10.1093","volume":"182","author":[{"given":"R","family":"Pasquali","sequence":"first","affiliation":[{"name":"1University Alma Mater Studiorum, Bologna, Italy"}]},{"given":"F","family":"Casanueva","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Santiago de Compostela University, Complejo Hospitalario Universitario de Santiago (CHUS), CIBER de Fisiopatologia Obesidad y Nutricion (CIBERobn ), Instituto Salud Carlos III, Santiago de Compostela, Spain"}]},{"given":"M","family":"Haluzik","sequence":"additional","affiliation":[{"name":"3Diabetes Centre and Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine and Institute of Endocrinology, Prague, Czech Republic"}]},{"given":"L","family":"van Hulsteijn","sequence":"additional","affiliation":[{"name":"4Department of Clinical Endocrinology and Metabolism, University Medical Centre Groningen, Groningen, the Netherlands"}]},{"given":"S","family":"Ledoux","sequence":"additional","affiliation":[{"name":"5Department of Physiology, Obesity Center, Louis Mourier Hospital (APHP), Colombes and Paris Diderot University, Paris, France"}]},{"given":"M P","family":"Monteiro","sequence":"additional","affiliation":[{"name":"6Endocrine, Cardiovascular & Metabolic Research, Unit for Multidisciplinary Research in Biomedicine (UMIB), Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar (ICBAS), University of Oporto, Porto, Portugal"},{"name":"7University College of London, London, UK"}]},{"given":"J","family":"Salvador","sequence":"additional","affiliation":[{"name":"8Department of Endocrinology and Nutrition, University Clinic of Navarra, Pamplona, Spain"},{"name":"9CIBEROBN, Instituto Carlos III, Madrid, Spain"}]},{"given":"F","family":"Santini","sequence":"additional","affiliation":[{"name":"10Obesity and Lipodystrophy Center, University Hospital of Pisa, Pisa, Italy"}]},{"given":"H","family":"Toplak","sequence":"additional","affiliation":[{"name":"11Division of Endocrinology and Diabetology, Department of Medicine, Medical University of Graz, Graz, Austria"}]},{"given":"O M","family":"Dekkers","sequence":"additional","affiliation":[{"name":"12Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands"},{"name":"13Department of Clinical Endocrinology and Metabolism, Leiden University Medical Centre, Leiden, the Netherlands"},{"name":"14Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}]}],"member":"286","container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/182\/1\/EJE-19-0893.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/182\/1\/EJE-19-0893.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:14:10Z","timestamp":1676391250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/182\/1\/G1\/6653910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/eje-19-0893","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}